Positive selection on the gene RNASEL: Correlation between patterns of evolution and function

Molecular Biology and Evolution

Volumn 29, Issue 10, 2012, Pages 3161-3168

  Jin, Wei ^a   Wu, Dong Dong ^b   Zhang, Xin ^a   Irwin, David M ^b,c,d   Zhang, Ya Ping ^a,b  

^a YUNNAN UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

positive selection; prostate cancer; RNASEL

Indexed keywords

ANKYRIN; PROTEIN RNASEL; RIBONUCLEASE; UNCLASSIFIED DRUG; VIRUS RNA;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CATALYSIS; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIMERIZATION; DNA SEQUENCE; EVOLUTION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MACACA FASCICULARIS; MUTATIONAL ANALYSIS; NONHUMAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIMATE; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN INTERACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; ENDORIBONUCLEASES; EVOLUTION, MOLECULAR; GENE FREQUENCY; GENETICS, POPULATION; GEOGRAPHY; HAPLOTYPES; HUMANS; INCIDENCE; LIKELIHOOD FUNCTIONS; MALE; MAMMALS; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; SELECTION, GENETIC; SOFTWARE;

PRIMATES;

EID: 84866931526     PISSN: 07374038     EISSN: 15371719     Source Type: Journal    
DOI: 10.1093/molbev/mss123     Document Type: Article

References (47)

1. Bandelt HJ, Forster P, Rohl A. 1999. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol. 16:37-48. (Pubitemid 29024937)
2. Birney E, Clamp M, Durbin R. 2004. GeneWise and genomewise. Genome Res. 14:988-995. (Pubitemid 38660520)
3. Bisbal C, Martinand C, Silhol M, Lebleu B, Salehzada T. 1995. Cloning and characterization of a RNase L inhibitor. J Biol Chem. 270:13308.
4. Bustamante CD, Fledel-Alon A, Williamson S, et al. (14 co-authors). 2005. Natural selection on protein-coding genes in the human genome. Nature 437:1153-1157. (Pubitemid 41509352)
5. Cann HM, De Toma C, Cazes L, et al. (41 co-authors). 2002. A human genome diversity cell line panel. Science 296: 261-262. (Pubitemid 34303653)
6. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E. 2002. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 30:181-184.
7. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM. 2002. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 32:581-583. (Pubitemid 35435169)
8. Cayley PJ, White RF, Antoniw JF, Walesby NJ, Kerr IM. 1982. Distribution of the ppp (A2'p) nA-binding protein and interferon-related enzymes in animals, plants, and lower organisms. Biochem Biophys Res Commun. 108:1243.
9. Crespi BJ, Summers K. 2006. Positive selection in the evolution of cancer. Biol Rev. 81:407-424. (Pubitemid 44092345)
10. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gr nberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. 2007. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 7:256-269. (Pubitemid 46486616)
11. Fay JC, Wu CI. 2000. Hitchhiking under positive Darwinian selection. Genetics 155:1405-1413. (Pubitemid 30463447)
12. Flodstrom-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, Fine C, Williams B, Silverman R, Sarvetnick N. 2005. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection 1. J Immunol. 174:1171-1177.
13. Fu YX. 1997. Statistical tests of neutrality of mutations against population growth, hitchhiking and background selection. Genetics 147:915-925.
14. Fu YX, Li WH. 1993. Statistical tests of neutrality of mutations. Genetics 133:693-709.
15. Guindon S, Gascuel O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol. 52:696-704. (Pubitemid 37365050)
16. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH. 1993. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12:3297.
17. Hwang YW, Kim SY, Jee SH, Kim YN, Nam CM. 2009. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer. 61:598-606.
18. Kimura T. 2011. East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians. Chin J Cancer. Advance Access published November 15, 2011, doi:10. 5732/cjc. 011. 10324
19. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. 2007. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 16:538-545. (Pubitemid 46548658)
20. Li H, Tai BC. 2006. RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis. Clin Cancer Res. 12:5713-5719. (Pubitemid 44629600)
21. Li JZ, Absher DM, Tang H, et al. (11 co-authors). 2008. Worldwide human relationships inferred from genome-wide patterns of variation. Science 319:1100-1104. (Pubitemid 351300793)
22. Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z. 2005. CDD: a conserved domain database for protein classification. Nucleic Acids Res. 33:D192-D196. (Pubitemid 40207858)
23. McDonald JH, Kreitman M. 1991. Adaptive protein evolution at the Adh locus in Drosophila. Nature 351:652-654. (Pubitemid 21896661)
24. Ng PC, Henikoff S. 2003. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31:3812-3814. (Pubitemid 37442253)
25. Nielsen R, Yang Z. 1998. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148:929-936. (Pubitemid 28169008)
26. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30:3894-3900. (Pubitemid 35012462)
27. Robbins CM, Hernandez W, Ahaghotu C, et al. (14 co-authors). 2008. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate 68:1790-1797.
28. Rokman A, Ikonen T, Seppälä EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP. 2002. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet. 70:1299-1304. (Pubitemid 34450579)
29. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R. 2003. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19:2496-2497. (Pubitemid 38016658)
30. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, Shamovsky O, Palma A, Mikkelsen TS, Altshuler D, Lander ES. 2006. Positive natural selection in the human lineage. Science 312:1614-1620. (Pubitemid 43902654)
31. Schaffner SF, Foo C, Gabriel S, Reich D, Daly MJ, Altshuler D. 2005. Calibrating a coalescent simulation of human genome sequence variation. Genome Res. 15:1576-1583. (Pubitemid 41545011)
32. Silverman RH. 2003. Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812. (Pubitemid 36258654)
33. Smith JR, Freije D, Carpten JD, et al. (23 co-authors). 1996. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371-1374. (Pubitemid 26391460)
34. Stephens M, Donnelly P. 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 73:1162-1169. (Pubitemid 37414228)
35. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 68:978-989. (Pubitemid 32289743)
36. Summers K, Crespi B. 2008. Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection. Infect Genet Evol. 8:297-301.
37. Tajima F. 1989. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595. (Pubitemid 19274682)
38. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4. 0. Mol Biol Evol. 24:1596-1599. (Pubitemid 47236692)
39. Vallender EJ, Lahn BT. 2004. Positive selection on the human genome. Hum Mol Genet. 13:245-254.
40. Van Valen L. 1973. A new evolutionary law. Evol Theory. 1:1-30.
41. Yan L, Spitznagel EL. 2009. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr. 89:1155-1163.
42. Yang Z. 1997. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci. 13:555-556. (Pubitemid 27480216)
43. Yang Z. 2000. Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J Mol Evol. 51:423-432.
44. Yang Z, Wong WSW, Nielsen R. 2005. Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol. 22:1107-1118. (Pubitemid 40471423)
45. Zhang J, Nielsen R, Yang Z. 2005. Evaluation of an improved branchsite likelihood method for detecting positive selection at the molecular level. Mol Biol Evol. 22:2472-2479. (Pubitemid 41661383)
46. Zhou A, Nie H, Silverman RH. 2000. Analysis and origins of the human and mouse RNase L genes: mediators of interferon action. Mamm Genome. 11:989-992.
47. Zhou A, Paranjape J, Brown TL, et al. (11 co-authors). 1997. Interferon action and apoptosis are defective in mice devoid of 2', 5'-oligoadenylate- dependent RNase L. EMBO J. 16:6355-6363. (Pubitemid 27483262)